Standard
A novel two-step transcriptional activation system for gene therapy directed toward epithelial cells. / Arendt, Maja Louise; Nasir, Lubna; Morgan, Iain M.
I:
Molecular Cancer Therapeutics, Bind 8, Nr. 12, 2009, s. 3244-3254.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Arendt, ML, Nasir, L & Morgan, IM 2009, '
A novel two-step transcriptional activation system for gene therapy directed toward epithelial cells',
Molecular Cancer Therapeutics, bind 8, nr. 12, s. 3244-3254.
https://doi.org/10.1158/1535-7163.MCT-09-0543
APA
Arendt, M. L., Nasir, L., & Morgan, I. M. (2009).
A novel two-step transcriptional activation system for gene therapy directed toward epithelial cells.
Molecular Cancer Therapeutics,
8(12), 3244-3254.
https://doi.org/10.1158/1535-7163.MCT-09-0543
Vancouver
Arendt ML, Nasir L, Morgan IM.
A novel two-step transcriptional activation system for gene therapy directed toward epithelial cells.
Molecular Cancer Therapeutics. 2009;8(12):3244-3254.
https://doi.org/10.1158/1535-7163.MCT-09-0543
Author
Arendt, Maja Louise ; Nasir, Lubna ; Morgan, Iain M. / A novel two-step transcriptional activation system for gene therapy directed toward epithelial cells. I: Molecular Cancer Therapeutics. 2009 ; Bind 8, Nr. 12. s. 3244-3254.
Bibtex
@article{fb5f5b603cb211df928f000ea68e967b,
title = "A novel two-step transcriptional activation system for gene therapy directed toward epithelial cells",
author = "Arendt, {Maja Louise} and Lubna Nasir and Morgan, {Iain M.}",
year = "2009",
doi = "10.1158/1535-7163.MCT-09-0543",
language = "English",
volume = "8",
pages = "3244--3254",
journal = "Molecular Cancer Therapeutics",
issn = "1535-7163",
publisher = "American Association for Cancer Research (A A C R)",
number = "12",
}
RIS
TY - JOUR
T1 - A novel two-step transcriptional activation system for gene therapy directed toward epithelial cells
AU - Arendt, Maja Louise
AU - Nasir, Lubna
AU - Morgan, Iain M.
PY - 2009
Y1 - 2009
U2 - 10.1158/1535-7163.MCT-09-0543
DO - 10.1158/1535-7163.MCT-09-0543
M3 - Journal article
C2 - 19952120
VL - 8
SP - 3244
EP - 3254
JO - Molecular Cancer Therapeutics
JF - Molecular Cancer Therapeutics
SN - 1535-7163
IS - 12
ER -
